Larry Lasagna

His investments include Kamcord, FiscalNote, Aarki, CreditSesame, HealthPocket which acquired by Health Insurance InnovationsHealth Insurance Innovations, Matcha which acquired by Apple, PasswordBox which acquired by McAfee/Intel, TrustGo which acquired by Baidu, GNS3 which was acquired by Solarwind, Flyr, Shippo, Virool, Skytree, eyeIO, and BookingPal.

The firm is interested in providing for companies that are focused on data-driven enterprise software, digital health technology, machine learning, artificial intelligence, Internet of Things, and cloud-based solutions. The firm has made a total of forty-nine investments in countries such as CrowdStreet, ZAPinfo, and TalkootTalkoot, inc.

SnapMD is a telemedicine platform in California that focuses on connecting individuals with pediatric physicians in the U.S. Founded 2013 in Glendale, California, United States by David Skibinski, Doug Campbell, George Tierney and Rustin Morse, SnapMD has raised a total of $16.3M in funding over five rounds. Their latest funding was raised on September 18, 2018 from a Series B round. SnapMD is funded by four investors. As of March 2020, Shea Ventures and TYLT VenturesTYLT Ventures are the most recent investors. The company's telemedicine platform conducts scheduled virtual consultations for patients receiving ongoing treatment, as well as conducts on-demand consultations to help reduce avoidable visits in urgent-care or emergency room settings, enabling health systems to improve access and deliver more convenient care to the patient at home, work or in other care settings.

His investments include Kamcord, FiscalNote, Aarki, CreditSesame, HealthPocket which acquired by Health Insurance Innovations, Matcha which acquired by Apple, PasswordBox which acquired by McAfee/Intel, TrustGo which acquired by Baidu, GNS3 which was acquired by Solarwind, Flyr, Shippo, Virool, Skytree, eyeIO, and BookingPalBookingPal.

SpyBiotech is a biomedical company in United KingdomUnited Kingdom that developed a method to bind antigens to virus like particles (VLPs) for vaccine development. The company focuses on producing vaccines more quickly, cheaply and effectively. Founded 2017 in Oxford, Oxfordshire, United Kingdom by Sumi Biswas, SpyBiotech has raised a total of £4M in funding over one round. This was a seed round raised on March 30, 2017. The company is funded by two investors, with Oxford Sciences Innovation and GV as the most recent investors. It operates a biotechnology platform intended to generate next-generation vaccines. The company's biotechnology platform is designed to develop vaccines using a proprietary protein superglue called SpyTag/SpyCatcher, which is used to attach antigens to VLPs. The goal of the technology is to provide medical institutions and research centers with a technology that could allow the development of better vaccines in less time.